Gilead Gets FDA Approval for Remdesivir for Some Non-Hospitalized Patients | MarketScreener

Retrieved on: 2022-01-22 00:11:37

Tags for this article:

Click the tags to see associated articles and topics

Gilead Gets FDA Approval for Remdesivir for Some Non-Hospitalized Patients | MarketScreener. View article details on hiswai:

Excerpt

By Josh Beckerman. Gilead Sciences Inc.'s remdesivir, commonly used to treat hospitalized Covid-19 patients, has received Food and Drug ...

Article found on: www.marketscreener.com